Status:

RECRUITING

Microvascular Monitoring in Circulatory Shock and Sepsis (MiMICSS)

Lead Sponsor:

University of Manitoba

Conditions:

Sepsis

Shock

Eligibility:

All Genders

18+ years

Brief Summary

Investigation of the feasibility of using near-infrared spectroscopy (NIRS) to monitor microvascular function in critically ill patients.

Detailed Description

This is a prospective observational study using non-invasive NIRS for microvascular monitoring in the ICU. The study involves no interventions above standard of care other than the application of the ...

Eligibility Criteria

Inclusion

  • Admitted to ICU
  • Receiving invasive mechanical ventilation

Exclusion

  • Body Mass Index \>40
  • More than 24 hours has elapsed since ICU admission
  • Death is deemed to be imminent and inevitable during the next 24 hours
  • Known allergy to the textile components of the device
  • Significant clinical jaundice, ecchymosis
  • COVID positive microbiological result
  • The treating clinician believes that participation in the domain would not be in the best interests of the patient
  • Consent declined from patient or authorized third party

Key Trial Info

Start Date :

May 27 2022

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

May 31 2026

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT05985525

Start Date

May 27 2022

End Date

May 31 2026

Last Update

August 24 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Health Sciences Centre Winnipeg

Winnipeg, Manitoba, Canada, R3A 1R9

Microvascular Monitoring in Circulatory Shock and Sepsis (MiMICSS) | DecenTrialz